Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of PARP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1404.86 | 1445 / 1445 | 100% | 15.49 | 183 / 183 |
ovary | 100% | 2104.07 | 180 / 180 | 100% | 18.45 | 430 / 430 |
uterus | 100% | 2071.72 | 170 / 170 | 100% | 27.82 | 459 / 459 |
brain | 100% | 2406.36 | 2637 / 2642 | 100% | 28.72 | 705 / 705 |
breast | 100% | 1761.51 | 459 / 459 | 99% | 19.88 | 1111 / 1118 |
lung | 99% | 1317.40 | 575 / 578 | 100% | 17.40 | 1152 / 1155 |
prostate | 100% | 1441.84 | 245 / 245 | 99% | 11.40 | 498 / 502 |
thymus | 100% | 1781.31 | 653 / 653 | 99% | 15.58 | 600 / 605 |
stomach | 100% | 1191.10 | 359 / 359 | 99% | 12.02 | 283 / 286 |
bladder | 100% | 1274.43 | 21 / 21 | 99% | 17.10 | 498 / 504 |
intestine | 100% | 1527.57 | 966 / 966 | 98% | 12.80 | 519 / 527 |
skin | 100% | 1621.97 | 1808 / 1809 | 99% | 15.07 | 465 / 472 |
pancreas | 100% | 947.45 | 328 / 328 | 98% | 12.51 | 175 / 178 |
liver | 100% | 844.03 | 226 / 226 | 98% | 11.20 | 396 / 406 |
adrenal gland | 100% | 1883.32 | 258 / 258 | 97% | 20.94 | 224 / 230 |
kidney | 100% | 1269.74 | 89 / 89 | 96% | 10.29 | 868 / 901 |
adipose | 100% | 1428.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.08 | 29 / 29 |
spleen | 100% | 1603.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.30 | 1 / 1 |
muscle | 100% | 1435.76 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1325.85 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 966.07 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 9.76 | 72 / 80 |
peripheral blood | 30% | 626.81 | 275 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0006281 | Biological process | DNA repair |
GO_0046697 | Biological process | decidualization |
GO_0061051 | Biological process | positive regulation of cell growth involved in cardiac muscle cell development |
GO_0006302 | Biological process | double-strand break repair |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0006974 | Biological process | DNA damage response |
GO_0030592 | Biological process | DNA ADP-ribosylation |
GO_0110088 | Biological process | hippocampal neuron apoptotic process |
GO_0070212 | Biological process | protein poly-ADP-ribosylation |
GO_0090649 | Biological process | response to oxygen-glucose deprivation |
GO_0006284 | Biological process | base-excision repair |
GO_0070213 | Biological process | protein auto-ADP-ribosylation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005634 | Cellular component | nucleus |
GO_0016779 | Molecular function | nucleotidyltransferase activity |
GO_0160004 | Molecular function | poly-ADP-D-ribose modification-dependent protein binding |
GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0140807 | Molecular function | NAD+-protein-glutamate ADP-ribosyltransferase activity |
GO_0140805 | Molecular function | NAD+-protein-serine ADP-ribosyltransferase activity |
GO_0140806 | Molecular function | NAD+- protein-aspartate ADP-ribosyltransferase activity |
GO_0072572 | Molecular function | poly-ADP-D-ribose binding |
GO_0140294 | Molecular function | NAD DNA ADP-ribosyltransferase activity |
GO_0031491 | Molecular function | nucleosome binding |
GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | PARP2 |
Protein name | Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.-) Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-) Poly(ADP-ribose) polymerase 2 |
Synonyms | ADPRTL2 ADPRT2 hCG_40481 |
Description | FUNCTION: Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair . Mediates glutamate, aspartate or serine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units . Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage . Mediates glutamate and aspartate ADP-ribosylation of target proteins in absence of HPF1 . Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 conferring serine specificity by completing the PARP2 active site . PARP2 initiates the repair of double-strand DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones, thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks . HPF1 initiates serine ADP-ribosylation but restricts the polymerase activity of PARP2 in order to limit the length of poly-ADP-ribose chains . Specifically mediates formation of branched poly-ADP-ribosylation . Branched poly-ADP-ribose chains are specifically recognized by some factors, such as APLF . In addition to proteins, also able to ADP-ribosylate DNA: preferentially acts on 5'-terminal phosphates at DNA strand breaks termini in nicked duplex . . |
Accessions | ENST00000250416.9 [Q9UGN5-1] ENST00000429687.8 [Q9UGN5-2] ENST00000539930.1 ENST00000527915.5 H0YH02 E9PJ27 G3V167 ENST00000708823.1 [Q9UGN5-1] ENST00000529465.6 Q9UGN5 ENST00000708822.1 [Q9UGN5-2] |